Glycine is also generally known as glycyrrhetinic acid diamine sodium chloride injection, whose main ingredient is glycyrrhetinic acid diamine, and is a drug for liver protection as well as for the treatment of chronic and acute viral hepatitis in patients. For patients with chronic viral hepatitis who have elevated glutathione transaminase, patients are generally advised to use diammonium glycyrrhizate sodium chloride for aggressive intravenous administration. It is generally recommended that the patient be injected for about 5-7 days, then after a week the patient should check the liver function if necessary to see how the patient’s glutamic and glutamic oxalacetic aminotransferases have decreased. If normal, the drug can be discontinued. However, drugs such as Glycine have certain side effects: first, the patient may have the possibility of shock, if the patient has the conditions, you can properly monitor blood pressure and heart rate to see the changes in the patient’s heart rate and blood pressure during the use of the drug. Second, it may cause an increase in aldosterone in the body, which may further cause the possibility of hypokalemia in patients. In addition, very few patients may experience increased blood pressure, dizziness, headache, nausea, and gastrointestinal discomfort. In these cases, the drug should be stopped and further treatment should be provided.